Pfizer: Shares Stabilize At $25 As Institutions Begin To Load Up (NYSE:PFE)
1. $25 support level indicates institutional buying interest in Pfizer. 2. Expansion into bladder cancer could significantly increase PFE's market reach. 3. Pfizer has $20.5B cash available for potential acquisitions. 4. Valuation metrics suggest PFE is alluring at 9x next year's cash flow. 5. Analyst revises opinion, now considers PFE a speculative buy.